Statements of Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands	Total	SERIES A CONVERTIBLE PREFERRED STOCK [Member]	SERIES B CONVERTIBLE PREFERRED STOCK [Member]	COMMON STOCK [Member]	ADDITIONAL PAID-IN CAPITAL [Member]	ACCUMULATED OTHER COMPREHENSIVE GAIN (LOSS) [Member]	ACCUMULATED DEFICIT [Member]
Beginning balance, Temporary equity (in Shares) at Dec. 31, 2022		3,673,148	2,487,237
Beginning balance, Temporary equity at Dec. 31, 2022		$ 96,767	$ 119,646
Beginning balance (in Shares) at Dec. 31, 2022				792,991
Beginning balance at Dec. 31, 2022	$ (140,696)				$ 11,895		$ (152,591)
Exercise of stock options (in Shares)				1,948
Exercise of stock options	10				10
Vesting of shares of common stock subject to repurchase, including early exercise (in Shares)				14,819
Vesting of shares of common stock subject to repurchase, including early exercise	30				30
Stock-based compensation expense	7,053				7,053
Unrealized gain (loss) on investments	308					$ 308
Net Income (Loss)	(28,720)						(28,720)
Ending balance, Temporary equity (in Shares) at Dec. 31, 2023		3,673,148	2,487,237
Ending balance, Temporary equity at Dec. 31, 2023		$ 96,767	$ 119,646
Ending balance (in Shares) at Dec. 31, 2023				809,758
Ending balance at Dec. 31, 2023	(162,015)				18,988	308	(181,311)
Conversion of preferred stock into common stock upon completion of initial public offering (IPO) (in Shares)		(3,673,148)	(2,487,237)
Conversion of preferred stock into common stock upon completion of initial public offering (IPO)		$ (96,767)	$ (119,646)
Conversion of preferred stock into common stock upon completion of initial public offering (IPO) (in Shares)				6,160,385
Conversion of preferred stock into common stock upon completion of initial public offering (IPO)	216,413			$ 1	216,412
Exercise of stock options (in Shares)				10,046
Exercise of stock options	51				51
Issuance of common shares in connection with IPO, net of offering costs (in Shares)				14,920,000
Issuance of common shares in connection with IPO, net of offering costs	162,325			$ 2	162,323
Issuance of common shares upon the conversion of SAFE notes (in Shares)				2,391,418
Issuance of common shares upon the conversion of SAFE notes	28,697				28,697
Stock-based compensation expense	6,980				6,980
Unrealized gain (loss) on investments	(437)					(437)
Net Income (Loss)	(65,373)						(65,373)
Ending balance, Temporary equity (in Shares) at Dec. 31, 2024			0
Ending balance (in Shares) at Dec. 31, 2024				24,291,607
Ending balance at Dec. 31, 2024	$ 186,641			$ 3	$ 433,451	$ (129)	$ (246,684)